{"id":12856,"date":"2011-11-01T10:27:07","date_gmt":"2011-11-01T14:27:07","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/?post_type=news&#038;p=12856"},"modified":"2011-11-01T10:27:07","modified_gmt":"2011-11-01T14:27:07","slug":"no-increased-risk-for-cv-events-with-adhd-drugs-large-study-finds","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2011\/11\/01\/no-increased-risk-for-cv-events-with-adhd-drugs-large-study-finds\/","title":{"rendered":"No Increased Risk for CV Events with ADHD Drugs, Large Study Finds"},"content":{"rendered":"<p>A <a href=\"www.nejm.org\/doi\/full\/10.1056\/NEJMoa1110212\">large new study<\/a> may help lay to rest concerns that the widely prescribed ADHD drugs may increase the risk for cardiovascular (CV) events.<\/p>\n<p>In a study funded by the Agency for Healthcare Research and Quality and the FDA and published in the<em>\u00a0New England Journal of Medicine<\/em>, William Cooper and colleagues analyzed data from 1.2 million children and young adults between 2 and 24 years of age\u00a0who were enrolled in four health plans; 373,667 person-years of current ADHD drug use were included.<\/p>\n<p>The investigators found a low rate of serious CV events (3.1 per 100,000 person-years) and no increase in risk for those taking ADHD drugs (adjusted HR 0.75, CI 0.31-1.85). The authors concluded that although their results did not find any increased risk, due to the wide confidence interval they were unable to rule out the possibility of a doubling in risk. &#8220;However,&#8221; they wrote, &#8220;the absolute magnitude of any increased risk would be low.&#8221;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A large new study may help lay to rest concerns that the widely prescribed ADHD drugs may increase the risk for cardiovascular (CV) events. In a study funded by the Agency for Healthcare Research and Quality and the FDA and published in the\u00a0New England Journal of Medicine, William Cooper and colleagues analyzed data from 1.2 [&hellip;]<\/p>\n","protected":false},"author":196,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,7],"tags":[1029],"class_list":["post-12856","post","type-post","status-publish","format-standard","hentry","category-general","category-prevention","tag-adhd-drugs"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/12856","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/196"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=12856"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/12856\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=12856"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=12856"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=12856"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}